Dietary n-3:n-6 fatty acid ratios differentially influence hormonal signature in a rodent model of metabolic syndrome relative to healthy controls
- Paul R Burghardt†1,
- Elyse S Kemmerer†2,
- Bradley J Buck2,
- Andrew J Osetek2,
- Charles Yan2,
- Lauren G Koch3,
- Steven L Britton3 and
- Simon J Evans†1, 2Email author
© Burghardt et al; licensee BioMed Central Ltd. 2010
Received: 11 March 2010
Accepted: 28 June 2010
Published: 28 June 2010
Dietary ratios of omega-3 (n-3) to omega-6 (n-6) polyunsaturated fatty acids (PUFAs) have been implicated in controlling markers of the metabolic syndrome, including insulin sensitivity, inflammation, lipid profiles and adiposity. However, the role of dietary PUFAs in regulating energy systems in healthy relative to metabolic diseased backgrounds has not been systematically addressed. We used dietary manipulation of n-3 to n-6 PUFA ratios in an animal model of metabolic syndrome and a related healthy line to assay feeding behavior and endocrine markers of feeding drive and energy regulation. Two related lines of rodents with a healthy and a metabolic syndrome phenotype were fed one of two isocaloric diets, comprised of either a 1:1 or a 1:30 n-3 to n-6 ratio, for 30 days. Food intake and weight gain were monitored; and leptin, ghrelin, adiponectin and a suite of hypothalamic neuropeptides involved in energy regulation were assayed following the dietary manipulation period. There was no difference in caloric intake or weight gain between diet groups, however there was a significant interaction between diet and phenotypic line on central and peripheral markers of energy homeostasis. Thus serum levels of leptin, acylated-ghrelin and adiponectin, and mRNA levels of the anorexigenic hypothalamic neuropeptide, cocaine-amphetamine related transcript (CART), showed differential, dietary responses with HCR rats showing an increase in anorexigenic signals in response to unbalanced n-3:6 ratios, while LCR did not. These data are the first to demonstrate that a rodent line with a metabolic syndrome-like phenotype responds differentially to dietary manipulation of n-3 and n-6 fatty acids relative to a related healthy line with regard to endocrine markers of energy homeostasis. The dietary n-3:n-6 ratios used in this experiment represent extreme points of natural human diets, however the data suggest that optimal recommendations regarding omega-3 and omega-6 intake may have differing effects in healthy subjects relative to metabolic syndrome patients. Further research is necessary to establish these responses in human populations.
A dietary constituent that may have remediating effects on metabolic syndrome are the polyunsaturated fatty acids (PUFA) in the omega-3 (n-3) class. Supplementation with the long chain n-3 PUFA has been shown to decrease insulin resistance, triglyceride levels, heart rate, and blood pressure, and increase HDL cholesterol levels . Conversely, omega-6 (n-6) PUFA, which compete with n-3s for several physiological processes and are abundant in the western diet , can increase inflammatory signals and have been associated with cardiovascular heart disease (CHD) .
Given the many opposing effects of n-3s compared to n-6s, recent studies have begun to dissect how the dietary ratios of these PUFA influence health and disease. While many n-6 derived eicosanoids propagate inflammatory signals, many n-3 derived eicosanoids are less inflammatory and even anti-inflammatory by competition . Therefore, diets with higher n-6 to n-3 ratios may contribute to the pathology of metabolic syndrome through inflammatory processes and other currently unrecognized mechanisms. It should be pointed out that the relationship between n-3 and n-6 PUFA is complex and they are not always in opposition. For example, the n-6 derived lipoxins have anti-inflammatory effects. Nevertheless, the dietary-influenced tissue ratios of n-3 to n-6 PUFA are important in their contribution to health and disease .
Recently, a naturalistic rodent model of metabolic syndrome was developed via selective breeding for intrinsic running capacity . This selection strategy resulted in animals with high or low intrinsic running capacity, referred to as high capacity runners (HCR) and low capacity runners (LCR), respectively. After several generations of selection and breeding, LCR rats developed numerous markers of metabolic syndrome, including, elevated LDL cholesterol, blood pressure, triglycerides, fasting glucose, insulin, C-reactive protein, and visceral adiposity. Conversely, HCR animals appeared physiologically healthy with a number of their metabolic parameters and intrinsic treadmill capacity falling within ranges reported for standard inbred strains [6, 7].
In the present study, we fed HCR and LCR lines one of two isocaloric diets, identical in total macronutrient composition. They differed only in the fat source to establish an unbalanced (30:1 n-6 to n-3) or balanced (1:1 n-6 to n-3) ratio of n-6s to n-3s, to mirror the extremes of the range of ratios reported in different human populations [3, 8]. Following dietary manipulation, we evaluated food intake and weight gain, circulating hormone levels related to energy management, and hypothalamic gene expression of neuropeptides involved in feeding and energy expenditure.
Animals and diets
Mineral Mix, AIN-93G-MX
Calcium Phosphate Dibasic
Vitamin Mix, AIN-93-VX
Fat Composition (g/kg)
Blood plasma feeding hormone detection
Blood plasma was isolated by centrifugation at 3000 rpm for 10 min and stored at -80°C. Commercially-available enzyme immunoassay kits were used to quantify the plasma levels of: leptin (Assay Designs, Ann Arbor, MI), acylated-ghrelin (Cayman Chemical, Ann Arbor, MI) and adiponectin (Alpco Diagnostics, Salem, NH), according to the manufacturer's instructions.
In situ hybridization analysis
Brains were sectioned and prepared for in situ hybridization and processed as previously described . Probes included 35S-labeled-antisense probes for the following transcripts: neuropeptide-Y (NPY; accession number: M20373), preproorexin (accession number: NM013179), agouti-related peptide (AgRP; accession number: AF206017), cocaine-amphetamine regulated transcript (CART; accession number: NM017110), and proopiomelanocortin (POMC; accession number: J00759).
The dependent variables of body weight, food intake, hormone level (leptin, ghrelin, adiponectin), and mRNA expression (AgRP, CART, MCH, NPY, orexin and POMC) were all analyzed by two-way analysis of variance (ANOVA). The independent variables of diet (balanced or unbalanced) and line (HCR or LCR) consisted of two levels. Tukey's honestly significant difference (HSD) was used for post hoc analysis to determine differences among individual groups, but only when significant interactions were found. For all analyses, Statistical Analysis Software (SAS) package (Cary, NC) was used, and statistical significance was set at p < 0.05.
Food intake and weight gain are similarly affected by balanced and unbalanced n-3:n-6 ratios
Circulating hormone levels respond differently to dietary manipulation
Dietary manipulation differentially affects CART expression in LCR and HCR rats
The results of this experiment are the first, to our knowledge, to show that manipulation of dietary n-6:n-3 PUFA ratios differentially affects an animal model of metabolic syndrome (LCR) as compared with a healthy related strain of rats (HCR). Peripheral and central drivers of energy homeostasis were differentially altered in HCR and LCR rats in response to unbalanced n-6:n-3 dietary ratios. Specifically, serum leptin, acylated-ghrelin and adiponectin were responsive to dietary manipulation in a line-specific manner. In the hypothalamus expression of the anorexigenic neuropeptide, CART, was different in the HCR and LCR animals following dietary n-6:n-3 manipulation. These data are indicative of an overall increase in orexigenic signal in a rat model of MetS (LCR) fed unbalanced relative to a balanced dietary n-6:n-3 ratio; and conversely, a significant decrease in orexigenic signal in healthy rodents (HCR) fed and unbalanced relative to a balanced dietary n-6:n-3 ratio.
Paradoxically, we did not see these hormonal signatures translate into increased feeding behavior. However, this might be explained in two ways. First, these measurements were all terminal endpoints and it's possible that the LCR rats on the unbalanced diet would have begun to eat more in time. Second, higher-level central control of feeding behavior [10, 11] may have superseded these changes to inhibit increased feeding behavior in the LCR animals on the unbalanced diet. In fact, we found no changes in orexin, NPY or POMC in hypothalamic feeding circuits, supporting this hypothesis.
In summary, the main finding in this study is the opposing response on several measures of energy management between a rodent model of MetS and a related healthy line, to dietary manipulation of n-6:n-3 fatty acid ratios. Taken as a whole, this study indicates that unbalanced dietary ratios of n-6:n-3 may exacerbate physiological conditions that contribute to disease in an at risk model of MetS, whereas a related healthy rodent line showed potential compensatory responses to counteract consumption of unbalanced dietary n-6:n-3 levels. Furthermore, these data suggest that dietary advice given to healthy individuals, regarding PUFA intake, may differentially affect those with metabolic syndrome.
Statement of Author Contributions are as Follows
P.R.B., E.S.K and S.J.E designed research; P.R.B, E.S.K, B.J.B, A.J.O, C.Y. and S.J.E conducted research; S.L.B and L.G.K. provided essential materials; P.R.B, E.S.K., and S.J.E. analyzed data; P.R.B., E.S.K. and S.J.E wrote paper, P.R.B and S.J.E. had primary responsibility for final content. All authors read and approved the final manuscript.
This work was supported by the Pritzker Neuropsychiatric Disorders Research Fund L.L.C., NIH Grants #1R21MH074999, #5T32HD007422-18, and #UL1RR024986.
- Carpentier YA, Portois L, Malaisse WJ: n-3 fatty acids and the metabolic syndrome. Am J Clin Nutr. 2006, 83: 1499S-1504S.Google Scholar
- Simopoulos AP: The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002, 56: 365-379. 10.1016/S0753-3322(02)00253-6.View ArticleGoogle Scholar
- Hibbeln JR, Nieminen LR, Blasbalg TL, Riggs JA, Lands WE: Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity. Am J Clin Nutr. 2006, 83: 1483S-1493S.Google Scholar
- Sijben JW, Calder PC: Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Proc Nutr Soc. 2007, 66: 237-259. 10.1017/S0029665107005472.View ArticleGoogle Scholar
- Koch LG, Britton SL: Artificial selection for intrinsic aerobic endurance running capacity in rats. Physiol Genomics. 2001, 5: 45-52.Google Scholar
- Wisloff U, Najjar SM, Ellingsen O, Haram PM, Swoap S, Al-Share Q, Fernstrom M, Rezaei K, Lee SJ, Koch LG, Britton SL: Cardiovascular risk factors emerge after artificial selection for low aerobic capacity. Science. 2005, 307: 418-420. 10.1126/science.1108177.View ArticleGoogle Scholar
- Barbato JC, Koch LG, Darvish A, Cicila GT, Metting PJ, Britton SL: Spectrum of aerobic endurance running performance in eleven inbred strains of rats. J Appl Physiol. 1998, 85: 530-536.Google Scholar
- Simopoulos AP: The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood). 2008, 233: 674-688. 10.3181/0711-MR-311.View ArticleGoogle Scholar
- Herman JP, Schafer MK, Young EA, Thompson R, Douglass J, Akil H, Watson SJ: Evidence for hippocampal regulation of neuroendocrine neurons of the hypothalamo-pituitary-adrenocortical axis. J Neurosci. 1989, 9: 3072-3082.Google Scholar
- Kelley AE, Baldo BA, Pratt WE, Will MJ: Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, action and reward. Physiol Behav. 2005, 86: 773-795. 10.1016/j.physbeh.2005.08.066.View ArticleGoogle Scholar
- Lutter M, Nestler EJ: Homeostatic and hedonic signals interact in the regulation of food intake. J Nutr. 2009, 139: 629-632. 10.3945/jn.108.097618.View ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.